We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$156B
1-Year Est. Return
27.51%
This Fund
S&P 500
This Quarter
Est. Return
+5.54%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$49.6B
AUM Growth
+$5.62B
(+13%)
Cap. Flow
+$2.56B
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
6.81%
Holding
1,885
New
111
Increased
738
Reduced
863
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$178M |
| 2 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$161M |
| 3 |
KLA
KLAC
|
+$151M |
| 4 |
Zions Bancorporation
ZION
|
+$148M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ingredion
INGR
|
+$85.6M |
| 2 |
Keysight
KEYS
|
+$83.3M |
| 3 |
ATI
ATI
|
+$81.4M |
| 4 |
Kennametal
KMT
|
+$66.6M |
| 5 |
Keurig Dr Pepper
KDP
|
+$65.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.46% |
| 2 | Industrials | 15.08% |
| 3 | Technology | 14.03% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Yum China
YUMC
$16.3B
| $2.65M | 0.01% |
57,460
-111
| -0.2% | -$4.82K |
|
1027
Halliburton
HAL
$26.6B
| $2.63M | 0.01% |
115,424
+13,292
| +13% | +$345K |
|
|
HES
1028
DELISTED
Hess
HES
| $2.62M | 0.01% |
41,270
-3,564
| -8% | -$220K |
|
1029
UDR
UDR
$12.4B
| $2.61M | 0.01% |
58,052
+54,014
| +1,338% | +$2.43M |
|
1030
Southern Company
SO
$107B
| $2.6M | 0.01% |
47,126
+31,970
| +211% | +$1.71M |
|
1031
Q32 Bio
QTTB
$490M
| $2.59M | 0.01% |
7,342
+2,776
| +61% | +$1.09M |
|
1032
Magna International
MGA
$19.2B
| $2.58M | 0.01% |
+52,000
| New | +$2.57M |
|
1033
Kelly Services Class A
KELYA
$528M
| $2.58M | 0.01% |
98,460
+14,100
| +17% | +$337K |
|
1034
Jones Lang LaSalle
JLL
$17.2B
| $2.58M | 0.01% |
18,313
+2,477
| +16% | +$352K |
|
1035
Malibu Boats
MBUU
$575M
| $2.56M | 0.01% |
65,963
-426
| -0.6% | -$16.9K |
|
1036
Columbus McKinnon
CMCO
$620M
| $2.55M | 0.01% |
60,810
+6,975
| +13% | +$265K |
|
1037
AudioCodes
AUDC
$251M
| $2.55M | 0.01% |
+164,602
| New | +$2.51M |
|
1038
United Therapeutics
UTHR
$22B
| $2.55M | 0.01% |
32,628
+9,266
| +40% | +$866K |
|
1039
Alexandria Real Estate Equities
ARE
$8.73B
| $2.54M | 0.01% |
17,996
-15,405
| -46% | -$2.22M |
|
|
COWN
1040
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $2.53M | 0.01% |
147,100
+28,750
| +24% | +$464K |
|
|
ALLK
1041
DELISTED
Allakos
ALLK
| $2.5M | 0.01% |
57,810
+12,250
| +27% | +$503K |
|
|
ATVI
1042
DELISTED
Activision Blizzard
ATVI
| $2.5M | 0.01% |
53,055
-50,523
| -49% | -$2.32M |
|
1043
Icon
ICLR
$12.6B
| $2.5M | 0.01% |
16,214
+421
| +3% | +$59K |
|
1044
Regeneron Pharmaceuticals
REGN
$79.1B
| $2.49M | 0.01% |
7,941
+38
| +0.5% | +$12.7K |
|
|
CIZ
1045
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
| $2.47M | 0.01% |
77,172
-7,581
| -9% | -$240K |
|
1046
Nike
NKE
$63B
| $2.47M | 0.01% |
29,454
+8,562
| +41% | +$721K |
|
1047
Bio-Rad Laboratories Class A
BIO
$9.31B
| $2.46M | 0.01% |
+7,855
| New | +$2.35M |
|
1048
Replimune Group
REPL
$994M
| $2.45M | ﹤0.01% |
167,180
-9,910
| -6% | -$143K |
|
1049
Ducommun
DCO
$2.89B
| $2.45M | ﹤0.01% |
54,350
-2,250
| -4% | -$101K |
|
1050
Oracle
ORCL
$416B
| $2.45M | ﹤0.01% |
43,001
+5,673
| +15% | +$307K |
|
Similar funds
Victory Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Victory Capital Management held 1,885 positions worth $49.6B, up 13% from $44B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Victory Capital Management deployed $2.56B of net new capital in Q2 2019, opening 111 new positions and adding to 738 existing holdings. Its largest new stake was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 3,081,520 shares worth $181M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Ingredion, an estimated $85.6M trimmed.
- Victory Capital Management's largest Q2 2019 buy was Goldman Sachs ActiveBeta US Large Cap Equity ETF: 3,081,520 shares worth $181M.
- Victory Capital Management added most to KLA in Q2 2019, an estimated $151M increase.
- Victory Capital Management's biggest Q2 2019 reduction was Ingredion, cutting an estimated $85.6M.
- Victory Capital Management fully exited Teladoc Health in Q2 2019, selling an estimated $50.5M.
- Victory Capital Management's ten largest holdings make up 6.8% of its $49.6B portfolio in Q2 2019.
- Victory Capital Management opened 111 new positions and closed 63 in Q2 2019.
- Victory Capital Management's portfolio value rose 13% quarter-over-quarter to $49.6B.
Based on Victory Capital Management's 13F filing for Q2 2019, filed 15 Aug 2019.